DGCA approves only 55.7% weekly domestic flights for winter schedule compared to last year
Currently, airlines in India are allowed to operate a maximum 60 percent of their pre-COVID-19 weekly domestic flights
New Delhi: The Directorate General of Civil Aviation (DGCA) said it has approved 12,983 weekly domestic flights of airlines for the winter schedule that begins on Sunday and ends on 27 March next year.
In last year's winter schedule, the aviation regulator had approved 23,307 weekly domestic flights.
The DGCA said on Sunday it has approved 6,006 weekly domestic flights of IndiGo for this year's winter schedule. IndiGo is India's largest airline. SpiceJet and GoAir have got 1,957 weekly domestic flights and 1,203 weekly domestic flights approved, the regulator said.
Currently, airlines in India are allowed to operate a maximum 60 percent of pre-COVID weekly domestic flights.
In comparison to last year's winter schedule, when 23,307 weekly domestic services were approved by the DGCA, this year's winter schedule has got just 55.7 percent (12,983 flights) of those flights approved, according to the aviation regulator.
These 55.7 percent flights will be operating from 95 Indian airports between 25 October and 27 March, 2021, the DGCA said.
India resumed scheduled domestic flights on 25 May after a gap of two months due to the coronavirus pandemic. At that time, airlines were permitted to operate just 33 per cent of their pre-COVID domestic flights. This figure was gradually increased in the later months.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
The toll due to the virus climbed to 1,36,696 with 496 new fatalities, as per the data updated at 8 am
Narendra Modi holds review meeting on COVID-19 vaccination strategy; regulatory approvals, procurement discussed
Additionally, Modi said, issues like prioritisation of population groups and tech platform for rolling out vaccine for the coronavirus were also brought up
Experts say the relatively small number of people in the low dose group makes it difficult to know if the effectiveness seen in the group is real or a statistical quirk.